After progress in Stage II trial using stem cells to regrow nerve fibres, the China Spinal Cord Injury Network (ChinaSCINet) has applied for regulatory approval for a third and final phase, which it hopes to start in the autumn.
“This will convince the doctors of the world that they do not need to tell patients ‘you will never walk again’,” US-based Doctor Wise Young, CEO of ChinaSCINet, said.
He said that 15 out of 20 patients in the Chinese city of Kunming, who received umbilical cord blood cell transplants and intensive walking therapy, were on average able to walk with minimal assistance seven years after complete spinal cord injury.
Read more… Press release from ChinaSCINet is available in English from the CareCure forum here.